Furthermore, we observed a trend towards significantly higher IL‐10 and IL‐4 expression at 48 hr, indicating that BML‐111 may be maximally effective at reducing pro‐inflammatory cytokines and increasing anti‐inflammatory cytokines 48 hr after stroke. The gene discussed is IL4; the disease is Stroke.